Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Hawkinson

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Circulation|December 1, 1989
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study GroupJ L Anderson, E M Gilbert, B L Alpert, et al.
American Heart Journal|August 11, 1992
Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study GroupA K Bhandari, J L Anderson, E M Gilbert, et al.
Clinical Therapeutics|January 1, 1989
Improved comfort and patient acceptance in a novel transdermal nitroglycerin delivery systemA J Hougham, R W Hawkinson, J K Crowley, et al.
Clinical Therapeutics|March 1, 1989
Performance of a new transdermal nitroglycerin adhesive patch formulationD J Riedel, K A Wick, R W Hawkinson, et al.
Clinical Therapeutics|January 1, 1989
Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery systemA J Hougham, R W Hawkinson, J K Crowley, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Circulation|December 1, 1989
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study GroupJ L Anderson, E M Gilbert, B L Alpert, et al.
American Heart Journal|August 11, 1992
Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study GroupA K Bhandari, J L Anderson, E M Gilbert, et al.
Clinical Therapeutics|January 1, 1989
Improved comfort and patient acceptance in a novel transdermal nitroglycerin delivery systemA J Hougham, R W Hawkinson, J K Crowley, et al.
Clinical Therapeutics|March 1, 1989
Performance of a new transdermal nitroglycerin adhesive patch formulationD J Riedel, K A Wick, R W Hawkinson, et al.
Clinical Therapeutics|January 1, 1989
Improved skin adherence and patient acceptance in a new transdermal nitroglycerin delivery systemA J Hougham, R W Hawkinson, J K Crowley, et al.
Pageof 2